abrdn Life Sciences Investors
HQL
45 hedge funds and large institutions have $40.7M invested in abrdn Life Sciences Investors in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 20 increasing their positions, 16 reducing their positions, and 8 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 16
6% more capital invested
Capital invested by funds: $38.3M → $40.7M (+$2.32M)
0.28% less ownership
Funds ownership: 11.52% → 11.24% (-0.28%)
10% less funds holding
Funds holding: 50 → 45 (-5)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$769K |
| 2 |
DA
Doliver Advisors
Houston,
Texas
|
+$491K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$407K |
| 4 |
NIM
Needham Investment Management
New York
|
+$403K |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$317K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Advisors Asset Management
Monument,
Colorado
|
-$880K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$692K |
| 3 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$532K |
| 4 |
Morgan Stanley
New York
|
-$291K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$287K |
HQL Hedge Fund Activity: Q3 2016 in Review
45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q3 2016, worth a combined $40.7M — up 6% from $38.3M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of HQL and 3 opened new positions — a net loss of 5 holders — while 16 trimmed existing stakes and 20 added.
The largest buyer was Citigroup, adding an estimated $769K. The largest seller was Advisors Asset Management, cutting an estimated $880K.
- 45 institutional investors held abrdn Life Sciences Investors (HQL) as of Q3 2016, down from 50 in Q2 2016.
- Funds reported $40.7M of abrdn Life Sciences Investors stock for Q3 2016, up 6% quarter-over-quarter.
- 3 funds opened new abrdn Life Sciences Investors positions in Q3 2016 and 8 closed out, a net change of -5 holders.
- The largest abrdn Life Sciences Investors buyer in Q3 2016 was Citigroup, an estimated $769K added.
- The largest abrdn Life Sciences Investors seller in Q3 2016 was Advisors Asset Management, an estimated $880K sold.
Based on aggregated 13F filings for Q3 2016.